{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T10:05:20Z","timestamp":1756893920455},"reference-count":50,"publisher":"American Diabetes Association","issue":"3","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,3,1]]},"abstract":"<jats:p>Diabetic retinopathy, one of the most serious complications of long-term diabetes, could clinically be divided into two stages: 1) background retinopathy that does not cause visual impairment and 2) proliferative retinopathy, which is a potentially blinding condition. This study aims to investigate the correlation between enhancement of vascular endothelial growth factor (VEGF) expression and neovascular changes. A binary recombinant adeno-associated virus construct producing green fluorescent protein (GFP) and VEGF under the control of the human cytomegalovirus promoter, recombinant adeno-associated virus (rAAV).VEGF.GFP, was produced and injected into the subretinal space of C57BL mice. GFP expression was tracked by fluorescence fundus photography, and VEGF expression was confirmed by immunohistochemistry and enzyme-linked immunoassay. Neovascular changes were monitored by fluorescein angiography and histology and by quantifying the number of inner retinal vessels. GFP expression was found in 100% of injected eyes, and vascular changes were detected in 9 of 10 rAAV.VEGF.GFP-injected eyes. Of these, four demonstrated microaneurysms and five showed moderate to severe leakage. There was a statistically significant increase in blood vessel number in the inner nuclear layer (P &amp;lt; 0.03) and dilatation of retinal veins (P \u2264 0.05). This work has demonstrated that the development of different stages of diabetic retinopathy is closely correlated with an increased VEGF level in the retina.<\/jats:p>","DOI":"10.2337\/diabetes.52.3.857","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"857-863","update-policy":"http:\/\/dx.doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":29,"title":["Enhanced Recombinant Adeno-Associated Virus-Mediated Vascular Endothelial Growth Factor Expression in the Adult Mouse Retina"],"prefix":"10.2337","volume":"52","author":[{"given":"P. Elizabeth","family":"Rakoczy","sequence":"first","affiliation":[{"name":"Centre of Ophthalmology and Visual Science, the University of Western Australia, Nedlands, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meliha","family":"Brankov","sequence":"additional","affiliation":[{"name":"Department of Molecular Ophthalmology, Lions Eye Institute of Western Australia, the University of Western Australia, Nedlands, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Fonceca","sequence":"additional","affiliation":[{"name":"Centre of Ophthalmology and Visual Science, the University of Western Australia, Nedlands, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tammy","family":"Zaknich","sequence":"additional","affiliation":[{"name":"Department of Molecular Ophthalmology, Lions Eye Institute of Western Australia, the University of Western Australia, Nedlands, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben C.","family":"Rae","sequence":"additional","affiliation":[{"name":"Department of Molecular Ophthalmology, Lions Eye Institute of Western Australia, the University of Western Australia, Nedlands, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chooi-May","family":"Lai","sequence":"additional","affiliation":[{"name":"Centre of Ophthalmology and Visual Science, the University of Western Australia, Nedlands, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","reference":[{"key":"2022031215440124000_R1","doi-asserted-by":"crossref","unstructured":"The Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report no. 4. Int Ophthalmol Clin\u200827:265\u2013272,1987","DOI":"10.1097\/00004397-198702740-00006"},{"key":"2022031215440124000_R2","doi-asserted-by":"crossref","unstructured":"The Diabetic Retinopathy Study Research Group: Indications for photocoagulation treatment of diabetic retinopathy: Diabetic Retinopathy Study report no. 14. Int Ophthalmol Clin\u200827:239\u2013253,1987","DOI":"10.1097\/00004397-198702740-00004"},{"key":"2022031215440124000_R3","doi-asserted-by":"crossref","unstructured":"Diabetes Control and Complications Trial Research Group: Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology\u2008102:647\u2013661,1995","DOI":"10.1016\/S0161-6420(95)30973-6"},{"key":"2022031215440124000_R4","doi-asserted-by":"crossref","unstructured":"Wipf JE, Paauw DS: Ophthalmologic emergencies in the patient with diabetes. Endocrinol Metab Clin North Am\u200829:813\u2013829,2000","DOI":"10.1016\/S0889-8529(05)70166-3"},{"key":"2022031215440124000_R5","doi-asserted-by":"crossref","unstructured":"Atkinson MA, Leiter EH: The NOD mouse model of type 1 diabetes: as good as it gets?Nat Med\u20085:601\u2013604,1999","DOI":"10.1038\/9442"},{"key":"2022031215440124000_R6","doi-asserted-by":"crossref","unstructured":"Cheta D: Animal models of type I (insulin-dependent) diabetes mellitus. J Pediatr Endocrinol Metab\u200811:11\u201319,1998","DOI":"10.1515\/JPEM.1998.11.1.11"},{"key":"2022031215440124000_R7","doi-asserted-by":"crossref","unstructured":"Sima AA, Chakrabarti S, Garcia-Salinas R, Basu PK: The BB-rat-an authentic model of human diabetic retinopathy. Curr Eye Res\u20084:1087\u20131092,1985","DOI":"10.3109\/02713688509003353"},{"key":"2022031215440124000_R8","doi-asserted-by":"crossref","unstructured":"Kador PF, Takahashi Y, Sato S, Wyman M: Amelioration of diabetes-like retinal changes in galactose-fed dogs. Prev Med\u200823:717\u2013721,1994","DOI":"10.1006\/pmed.1994.1122"},{"key":"2022031215440124000_R9","doi-asserted-by":"crossref","unstructured":"Kobayashi T, Kubo E, Takahashi Y, Kasahara T, Yonezawa H, Akagi Y: Retinal vessel changes in galactose-fed dogs. Arch Ophthalmol\u2008116:785\u2013789,1998","DOI":"10.1001\/archopht.116.6.785"},{"key":"2022031215440124000_R10","unstructured":"Miller JW, Adamis AP, Shima DT, D\u2019Amore PA, Moulton RS, O\u2019Reilly MS, Folkman J, Dvorak HF, Brown LF, Berse B: Vascular endothelial growth factor\/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol\u2008145:574\u2013584,1994"},{"key":"2022031215440124000_R11","doi-asserted-by":"crossref","unstructured":"Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med\u2008331:1480\u20131487,1994","DOI":"10.1056\/NEJM199412013312203"},{"key":"2022031215440124000_R12","doi-asserted-by":"crossref","unstructured":"Adamis AP, Miller JW, Bernal MT, D\u2019Amico DJ, Folkman J, Yeo TK, Yeo KT: Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol\u2008118:445\u2013450,1994","DOI":"10.1016\/S0002-9394(14)75794-0"},{"key":"2022031215440124000_R13","doi-asserted-by":"crossref","unstructured":"Malecaze F, Clamens S, Simorre-Pinatel V, Mathis A, Chollet P, Favard C, Bayard F, Plouet J: Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol\u2008112:1476\u20131482,1994","DOI":"10.1001\/archopht.1994.01090230090028"},{"key":"2022031215440124000_R14","doi-asserted-by":"crossref","unstructured":"Hammes HP, Lin J, Bretzel RG, Brownlee M, Breier G: Upregulation of the vascular endothelial growth factor\/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes\u200847:401\u2013406,1998","DOI":"10.2337\/diabetes.47.3.401"},{"key":"2022031215440124000_R15","doi-asserted-by":"crossref","unstructured":"Smythe GM, Lai MC, Grounds MD, Rakoczy PE: Adeno-associated virus-mediated VEGF gene therapy in skeletal muscle prior to transplantation promotes revascularisation of the regenerating muscle. Tissue Engineering\u20088:879\u2013891,2002","DOI":"10.1089\/10763270260424240"},{"key":"2022031215440124000_R16","unstructured":"McMenamin PG: Optimal methods for preparation and immunostaining of iris, ciliary body, and choroidal wholemounts. Invest Ophthalmol Vis Sci\u200841:3043\u20133048,2000"},{"key":"2022031215440124000_R17","doi-asserted-by":"crossref","unstructured":"Lai YK, Shen WY, Brankov M, Lai CM, Constable IJ, Rakoczy PE: Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy. Gene Ther\u20089:804\u2013813,2002","DOI":"10.1038\/sj.gt.3301695"},{"key":"2022031215440124000_R18","doi-asserted-by":"crossref","unstructured":"Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LE: Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A\u200892:10457\u201310461,1995","DOI":"10.1073\/pnas.92.23.10457"},{"key":"2022031215440124000_R19","unstructured":"Gilbert RE, Vranes D, Berka JL, Kelly DJ, Cox A, Wu LL, Stacker SA, Cooper ME: Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Lab Invest\u200878:1017\u20131027,1998"},{"key":"2022031215440124000_R20","unstructured":"Kim I, Ryan AM, Rohan R, Amano S, Agular S, Miller JW, Adamis AP: Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. Invest Ophthalmol Vis Sci\u200840:2115\u20132121,1999"},{"key":"2022031215440124000_R21","doi-asserted-by":"crossref","unstructured":"Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science\u2008219:983\u2013985,1983","DOI":"10.1126\/science.6823562"},{"key":"2022031215440124000_R22","doi-asserted-by":"crossref","unstructured":"Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science\u2008246:1309\u20131312,1989","DOI":"10.1126\/science.2479987"},{"key":"2022031215440124000_R23","doi-asserted-by":"crossref","unstructured":"Connolly DT: Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biochem\u200847:219\u2013223,1991","DOI":"10.1002\/jcb.240470306"},{"key":"2022031215440124000_R24","unstructured":"Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D\u2019Amato RJ: A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci\u200837:1625\u20131632,1996"},{"key":"2022031215440124000_R25","doi-asserted-by":"crossref","unstructured":"Spilsbury K, Garrett KL, Shen WY, Constable IJ, Rakoczy PE: Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol\u2008157:135\u2013144,2000","DOI":"10.1016\/S0002-9440(10)64525-7"},{"key":"2022031215440124000_R26","doi-asserted-by":"crossref","unstructured":"Anglade E, Csaky KG: Recombinant adenovirus-mediated gene transfer into the adult rat retina. Curr Eye Res\u200817:316\u2013321,1998","DOI":"10.1076\/ceyr.17.3.316.5221"},{"key":"2022031215440124000_R27","unstructured":"Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle W, Zack DJ, Campochiaro PA: Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol\u2008151:281\u2013291,1997"},{"key":"2022031215440124000_R28","doi-asserted-by":"crossref","unstructured":"Ohno-Matsui K, Hirose A, Yamamoto S, Saikia J, Okamoto N, Gehlbach P, Duh EJ, Hackett S, Chang M, Bok D, Zack DJ, Campochiaro PA: Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment. Am J Pathol\u2008160:711\u2013719,2002","DOI":"10.1016\/S0002-9440(10)64891-2"},{"key":"2022031215440124000_R29","doi-asserted-by":"crossref","unstructured":"Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med\u20081:27\u201331,1995","DOI":"10.1038\/nm0195-27"},{"key":"2022031215440124000_R30","doi-asserted-by":"crossref","unstructured":"Sakamoto T, Ueno H, Goto Y, Oshima Y, Yamanaka I, Ishibashi T, Inomata H: Retinal functional change caused by adenoviral vector-mediated transfection of LacZ gene. Hum Gene Ther\u20089:789\u2013799,1998","DOI":"10.1089\/hum.1998.9.6-789"},{"key":"2022031215440124000_R31","doi-asserted-by":"crossref","unstructured":"Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, Cideciyan AV, Pearce-Kelling SE, Anand V, Zeng Y, Maguire AM, Jacobson SG, Hauswirth WW, Bennett J: Gene therapy restores vision in a canine model of childhood blindness. Nat Genet\u200828:92\u201395,2001","DOI":"10.1038\/ng0501-92"},{"key":"2022031215440124000_R32","doi-asserted-by":"crossref","unstructured":"Rolling F, Shen WY, Barnett NL, Tabarias H, Kanagasingam Y, Constable I, Rakoczy PE: Long-term real-time monitoring of adeno-associated virus-mediated gene expression in the rat retina. Clin Experiment Ophthalmol\u200828:382\u2013386,2000","DOI":"10.1046\/j.1442-9071.2000.00341.x"},{"key":"2022031215440124000_R33","doi-asserted-by":"crossref","unstructured":"Bennett J, Maguire AM, Cideciyan AV, Schnell M, Glover E, Anand V, Aleman TS, Chirmule N, Gupta AR, Huang Y, Gao GP, Nyberg WC, Tazelaar J, Hughes J, Wilson JM, Jacobson SG: Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci U S A\u200896:9920\u20139925,1999","DOI":"10.1073\/pnas.96.17.9920"},{"key":"2022031215440124000_R34","unstructured":"Bennett J, Duan D, Engelhardt JF, Maguire AM: Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction. Invest Ophthalmol Vis Sci\u200838:2857\u20132863,1997"},{"key":"2022031215440124000_R35","doi-asserted-by":"crossref","unstructured":"Rolling F, Shen WY, Tabarias H, Constable I, Kanagasingam Y, Barry CJ, Rakoczy PE: Evaluation of adeno-associated virus-mediated gene transfer into the rat retina by clinical fluorescence photography. Hum Gene Ther\u200810:641\u2013648,1999","DOI":"10.1089\/10430349950018715"},{"key":"2022031215440124000_R36","unstructured":"Tobe T, Okamoto N, Vinores MA, Derevjanik NL, Vinores SA, Zack DJ, Campochiaro PA: Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci\u200839:180\u2013188,1998"},{"key":"2022031215440124000_R37","doi-asserted-by":"crossref","unstructured":"Volpert O, Jackson D, Bouck N, Linzer DI: The insulin-like growth factor II\/mannose 6-phosphate receptor is required for proliferin-induced angiogenesis. Endocrinology\u2008137:3871\u20133876,1996","DOI":"10.1210\/endo.137.9.8756559"},{"key":"2022031215440124000_R38","doi-asserted-by":"crossref","unstructured":"Frank RN, Amin RH, Eliott D, Puklin JE, Abrams GW: Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol\u2008122:393\u2013403,1996","DOI":"10.1016\/S0002-9394(14)72066-5"},{"key":"2022031215440124000_R39","doi-asserted-by":"crossref","unstructured":"Kliffen M, Sharma HS, Mooy CM, Kerkvliet S, de Jong PT: Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol\u200881:154\u2013162,1997","DOI":"10.1136\/bjo.81.2.154"},{"key":"2022031215440124000_R40","doi-asserted-by":"crossref","unstructured":"Pepper MS: Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol\u200821:1104\u20131117,2001","DOI":"10.1161\/hq0701.093685"},{"key":"2022031215440124000_R41","doi-asserted-by":"crossref","unstructured":"Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD: The codependence of angiogenesis and chronic inflammation. FASEB J\u200811:457\u2013465,1997","DOI":"10.1096\/fasebj.11.6.9194526"},{"key":"2022031215440124000_R42","doi-asserted-by":"crossref","unstructured":"Hata Y, Nakagawa K, Ishibashi T, Inomata H, Ueno H, Sueishi K: Hypoxia-induced expression of vascular endothelial growth factor by retinal glial cells promotes in vitro angiogenesis. Virchows Arch\u2008426:479\u2013486,1995","DOI":"10.1007\/BF00193171"},{"key":"2022031215440124000_R43","doi-asserted-by":"crossref","unstructured":"Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA: Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol\u2008113:1538\u20131544,1995","DOI":"10.1001\/archopht.1995.01100120068012"},{"key":"2022031215440124000_R44","doi-asserted-by":"crossref","unstructured":"Yan Q, Li Y, Hendrickson A, Sage EH: Regulation of retinal capillary cells by basic fibroblast growth factor, vascular endothelial growth factor, and hypoxia. In Vitro Cell Dev Biol Anim\u200837:45\u201349,2001","DOI":"10.1290\/1071-2690(2001)037<0045:RORCCB>2.0.CO;2"},{"key":"2022031215440124000_R45","doi-asserted-by":"crossref","unstructured":"Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W: Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol\u2008140:947\u2013959,1998","DOI":"10.1083\/jcb.140.4.947"},{"key":"2022031215440124000_R46","doi-asserted-by":"crossref","unstructured":"Ferrara N: The role of vascular endothelial growth factor in the regulation of blood vessel growth. In Tumour Angiogenesis. Bicknell R, Lewis CE, Ferrara N, Eds. New York, Oxford University Press,1997, p.185\u2013199","DOI":"10.1093\/oso\/9780198549376.003.0016"},{"key":"2022031215440124000_R47","doi-asserted-by":"crossref","unstructured":"Kristinsson JK, Gottfredsdottir MS, Stefansson E: Retinal vessel dilatation and elongation precedes diabetic macular oedema. Br J Ophthalmol\u200881:274\u2013278,1997","DOI":"10.1136\/bjo.81.4.274"},{"key":"2022031215440124000_R48","unstructured":"Lu M, Amano S, Miyamoto K, Garland R, Keough K, Qin W, Adamis AP: Insulin-induced vascular endothelial growth factor expression in retina. Invest Ophthalmol Vis Sci\u200840:3281\u20133286,1999"},{"key":"2022031215440124000_R49","doi-asserted-by":"crossref","unstructured":"Pettersson A, Nagy JA, Brown LF, Sundberg C, Morgan E, Jungles S, Carter R, Krieger JE, Manseau EJ, Harvey VS, Eckelhoefer IA, Feng D, Dvorak AM, Mulligan RC, Dvorak HF: Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor\/vascular endothelial growth factor. Lab Invest\u200880:99\u2013115,2000","DOI":"10.1038\/labinvest.3780013"},{"key":"2022031215440124000_R50","doi-asserted-by":"crossref","unstructured":"Tolentino MJ, McLeod DS, Taomoto M, Otsuji T, Adamis AP, Lutty GA: Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate. Am J Ophthalmol\u2008133:373\u2013385,2002","DOI":"10.1016\/S0002-9394(01)01381-2"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/52\/3\/857\/373809\/db0303000857.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/52\/3\/857\/373809\/db0303000857.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T14:01:29Z","timestamp":1707660089000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/52\/3\/857\/23975\/Enhanced-Recombinant-Adeno-Associated-Virus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,1]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.52.3.857","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,1]]}}}